# Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes

> **NCT03020459** · NA · COMPLETED · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Macular Hole
- Surgery

## Interventions

- **PROCEDURE:** peeling-reposition
- **PROCEDURE:** peeling
- **DRUG:** Brilliant Blue G
- **OTHER:** postoperative posture
- **DEVICE:** Constellation 23-gauge vitrectomy system

## Key facts

- **NCT ID:** NCT03020459
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-08-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020459, "Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03020459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*